Volume 46, Issue 3 , Pages 415-423, September 2005
Earlier Diagnosis of Autosomal Dominant Polycystic Kidney Disease: Importance of Family History and Implications for Cardiovascular and Renal Complications
Background: Autosomal dominant polycystic kidney disease (ADPKD) is a common and serious cause of hereditary renal disease. The emerging possibilities to intervene early in the disease course elevate the importance of both accurate and early diagnosis of ADPKD. Family history analysis is a simple and inexpensive approach to identifying individuals at risk for ADPKD. We hypothesized that advances in knowledge of and potential interventions for ADPKD have led to increased use of family history screening. Methods: We distributed surveys to 1,527 subjects from our ADPKD research database to determine the extent to which examination of family history was used to diagnose ADPKD, by birth cohort. Results: Six hundred thirty-seven subjects with ADPKD (42%) completed and returned surveys. Family history analysis led to the initial ADPKD diagnosis in 49% of all subjects overall. In the birth-cohort analysis, ADPKD was more likely to have been diagnosed in individuals born between 1951 and 1974 because of family history (55% versus 38%; P < 0.0002) and patients were younger at diagnosis (27 versus 39 years; P < 0.0001) than individuals born before 1951. Conclusion: In a large cohort of subjects with ADPKD, we found increased use of family history analysis as a tool for diagnosing ADPKD and earlier age of diagnosis in the more recent birth cohort. This trend may reflect increased overall awareness of ADPKD by physicians, as well as encouraging hypertension and proteinuria treatment outcome data that may depend on intervening early in the course of disease.
Index Words: Autosomal dominant polycystic kidney disease (ADPKD) , diagnosis , hypertension
To access this article, please choose from the options below
Originally published online as doi:10.1053/j.ajkd.2005.05.029 on July 25, 2005Supported in part by grant no. P01 DK34039 from the National Institute of Diabetes and Digestive and Kidney Diseases; grants no. MO1 RR00051 and M01 RR00069 from the General Clinical Research Centers Program of the National Center for Research Resources, The National Institutes of Health; and the Zell Family Foundation.
PII: S0272-6386(05)00782-1
doi:10.1053/j.ajkd.2005.05.029
© 2005 National Kidney Foundation, Inc. Published by Elsevier Inc All rights reserved.
Volume 46, Issue 3 , Pages 415-423, September 2005
